Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026)

Verano Holdings (VRNO) reported Other Non-Current Liabilities of $156000.0 for Q1 2026, down 93.71% year-over-year from $2.5 million in Q1 2025, and down 42.22% quarter-over-quarter from $270000.0 in Q4 2025.

Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 5 years of Other Non-Current Liabilities data on file, last reported at $156000.0 in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $156000.0, down 93.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $156000.0 (down 93.71% YoY), and the FY2025 annual result was $270000.0, down 85.87% from the prior year.
  • Other Non-Current Liabilities slipped to $156000.0 in Q1 2026 per VRNO's latest filing, from $270000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $53.7 million in Q3 2022 and troughed at $156000.0 in Q1 2026.
  • A 5-year average of $6.4 million and a median of $3.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities tumbled 95.75% in 2023, then jumped 649.41% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $6.0 million in 2022, then plunged by 95.75% to $255000.0 in 2023, then jumped by 649.41% to $1.9 million in 2024, then slumped by 85.87% to $270000.0 in 2025, then plunged by 42.22% to $156000.0 in 2026.
  • Business Quant data shows VRNO's Other Non-Current Liabilities at $156000.0 in Q1 2026, $270000.0 in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Verano Holdings - - 98.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 156,000.00
Dec 31, 2025 270,000.00
Sep 30, 2025 2.16 Mn
Jun 30, 2025 1.42 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 5.01 Mn
Jun 30, 2024 3.78 Mn
Mar 31, 2024 3.24 Mn
Dec 31, 2023 255,000.00
Sep 30, 2023 4.95 Mn
Jun 30, 2023 4.95 Mn
Mar 31, 2023 5.74 Mn
Dec 31, 2022 5.99 Mn
Sep 30, 2022 53.74 Mn